LAMBDA ASSET PURCHASE AGREEMENT by and between EIGER INNOTHERAPEUTICS, INC., as Purchaser, and EIGER BIOPHARMACEUTICALS, INC., as Seller Dated as of August 1, 2024Lambda Asset Purchase Agreement • August 2nd, 2024 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 2nd, 2024 Company Industry JurisdictionTHIS LAMBDA ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of August 1, 2024 (the “Agreement Date”) is entered into by and between Eiger InnoTherapeutics, Inc., a Delaware corporation (“Purchaser”) and Eiger BioPharmaceuticals, Inc., a Delaware corporation (the “Seller”).